Next Article in Journal
Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes
Previous Article in Journal
Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways
Previous Article in Special Issue
Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer’s Disease
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessReview
Nutrients 2017, 9(9), 1017; doi:10.3390/nu9091017

A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders

Neuromuscular Reference Centre, Ghent University Hospital, 9000 Ghent, Belgium
Department of Pediatrics-Division of Pediatric Neurology and Metabolism, Ghent University Hospital, 9000 Ghent, Belgium
Author to whom correspondence should be addressed.
Received: 8 August 2017 / Revised: 1 September 2017 / Accepted: 11 September 2017 / Published: 14 September 2017
(This article belongs to the Special Issue Effects of Resveratrol Supplementation on Human Health and Disease)
View Full-Text   |   Download PDF [932 KB, uploaded 14 September 2017]   |  


In human cells, mitochondria provide the largest part of cellular energy in the form of adenosine triphosphate generated by the process of oxidative phosphorylation (OXPHOS). Impaired OXPHOS activity leads to a heterogeneous group of inherited diseases for which therapeutic options today remain very limited. Potential innovative strategies aim to ameliorate mitochondrial function by increasing the total mitochondrial load of tissues and/or to scavenge the excess of reactive oxygen species generated by OXPHOS malfunctioning. In this respect, resveratrol, a compound that conveniently combines mitogenetic with antioxidant activities and, as a bonus, possesses anti-apoptotic properties, has come forward as a promising nutraceutical. We review the scientific evidence gathered so far through experiments in both in vitro and in vivo systems, evaluating the therapeutic effect that resveratrol is expected to generate in mitochondrial patients. The obtained results are encouraging, but clearly show that achieving normalization of OXPHOS function with this strategy alone could prove to be an unattainable goal. View Full-Text
Keywords: mitochondrial biogenesis; mitochondrial disorders; oxidative phosphorylation; resveratrol mitochondrial biogenesis; mitochondrial disorders; oxidative phosphorylation; resveratrol

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

De Paepe, B.; Van Coster, R. A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders. Nutrients 2017, 9, 1017.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top